These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 9185588)
1. Transactivation of prothymosin alpha and c-myc promoters by human papillomavirus type 16 E6 protein. Kinoshita T; Shirasawa H; Shino Y; Moriya H; Desbarats L; Eilers M; Simizu B Virology; 1997 May; 232(1):53-61. PubMed ID: 9185588 [TBL] [Abstract][Full Text] [Related]
2. Position and orientation independent transactivation by c-Myc. Packham G; Bello-Fernandez C; Cleveland JL Cell Mol Biol Res; 1994; 40(7-8):699-706. PubMed ID: 7787888 [TBL] [Abstract][Full Text] [Related]
3. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner. López-Ocejo O; Viloria-Petit A; Bequet-Romero M; Mukhopadhyay D; Rak J; Kerbel RS Oncogene; 2000 Sep; 19(40):4611-20. PubMed ID: 11030150 [TBL] [Abstract][Full Text] [Related]
4. Bin1 functionally interacts with Myc and inhibits cell proliferation via multiple mechanisms. Elliott K; Sakamuro D; Basu A; Du W; Wunner W; Staller P; Gaubatz S; Zhang H; Prochownik E; Eilers M; Prendergast GC Oncogene; 1999 Jun; 18(24):3564-73. PubMed ID: 10380878 [TBL] [Abstract][Full Text] [Related]
5. Dispensability of p53 degradation for tumorigenicity and decreased serum requirement of human papillomavirus type 16 E6. Inoue T; Oka K; Yong-Il H; Vousden KH; Kyo S; Jing P; Hakura A; Yutsudo M Mol Carcinog; 1998 Mar; 21(3):215-22. PubMed ID: 9537653 [TBL] [Abstract][Full Text] [Related]
6. The E6 protein of human papillomavirus type 16 functions as a transcriptional repressor in a mechanism independent of the tumor suppressor protein, p53. Etscheid BG; Foster SA; Galloway DA Virology; 1994 Dec; 205(2):583-5. PubMed ID: 7975261 [TBL] [Abstract][Full Text] [Related]
7. Do products of the myc proto-oncogene play a role in transcriptional regulation of the prothymosin alpha gene? Mol PC; Wang RH; Batey DW; Lee LA; Dang CV; Berger SL Mol Cell Biol; 1995 Dec; 15(12):6999-7009. PubMed ID: 8524267 [TBL] [Abstract][Full Text] [Related]
8. Transcription-modulatory activity of full-length E6 and E6*I proteins of human papillomavirus type 16. Shirasawa H; Jin MH; Shimizu K; Akutsu N; Shino Y; Simizu B Virology; 1994 Aug; 203(1):36-42. PubMed ID: 8030282 [TBL] [Abstract][Full Text] [Related]
9. The role of HPV oncoproteins and cellular factors in maintenance of hTERT expression in cervical carcinoma cells. Jeong Seo E; Jung Kim H; Jae Lee C; Tae Kang H; Seong Hwang E Gynecol Oncol; 2004 Jul; 94(1):40-7. PubMed ID: 15262117 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of prothymosin alpha, concomitant with c-myc, during rat hepatic carcinogenesis. Wu CG; Boers W; Reitsma PR; van Deventer SJ; Chamuleau RA Biochem Biophys Res Commun; 1997 Mar; 232(3):817-21. PubMed ID: 9126360 [TBL] [Abstract][Full Text] [Related]
11. Effect of human papillomavirus type 16 E6 and E7 oncogenes on the activity of the transforming growth factor-beta2 (TGF-beta2) promoter. Murvai M; Borbély AA; Kónya J; Gergely L; Veress G Arch Virol; 2004 Dec; 149(12):2379-92. PubMed ID: 15290353 [TBL] [Abstract][Full Text] [Related]
12. Induction of the p53-target gene GADD45 in HPV-positive cancer cells. Butz K; Whitaker N; Denk C; Ullmann A; Geisen C; Hoppe-Seyler F Oncogene; 1999 Apr; 18(14):2381-6. PubMed ID: 10327059 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of serum- and calcium-induced terminal differentiation of human keratinocytes by HPV 16 E6: study of the association with p53 degradation, inhibition of p53 transactivation, and binding to E6BP. Sherman L; Itzhaki H; Jackman A; Chen JJ; Koval D; Schlegel R Virology; 2002 Jan; 292(2):309-20. PubMed ID: 11878933 [TBL] [Abstract][Full Text] [Related]
14. Opposite transcriptional activity between the wild type c-myc gene coding for c-Myc1 and c-Myc2 proteins and c-Myc1 and c-Myc2 separately. Batsché E; Crémisi C Oncogene; 1999 Oct; 18(41):5662-71. PubMed ID: 10523846 [TBL] [Abstract][Full Text] [Related]
15. The early HPV16 proteins can regulate mRNA levels of cell cycle genes in human cervical carcinoma cells by p53-independent mechanisms. Fogel S; Riou G Virology; 1998 Apr; 244(1):97-107. PubMed ID: 9581783 [TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus type 16 E6 and E7 oncoproteins upregulate c-IAP2 gene expression and confer resistance to apoptosis. Yuan H; Fu F; Zhuo J; Wang W; Nishitani J; An DS; Chen IS; Liu X Oncogene; 2005 Jul; 24(32):5069-78. PubMed ID: 15856013 [TBL] [Abstract][Full Text] [Related]
17. Targetting of the N-terminal domain of the human papillomavirus type 16 E6 oncoprotein with monomeric ScFvs blocks the E6-mediated degradation of cellular p53. Giovane C; Trave G; Briones A; Lutz Y; Wasylyk B; Weiss E J Mol Recognit; 1999; 12(2):141-52. PubMed ID: 10398405 [TBL] [Abstract][Full Text] [Related]
18. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes. Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737 [TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus E6 and Myc proteins associate in vivo and bind to and cooperatively activate the telomerase reverse transcriptase promoter. Veldman T; Liu X; Yuan H; Schlegel R Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8211-6. PubMed ID: 12821782 [TBL] [Abstract][Full Text] [Related]
20. Mutational analysis of transcriptional activation by the bovine papillomavirus type 1 E6. Chen JJ; Hong Y; Androphy EJ Virology; 1997 Sep; 236(1):30-6. PubMed ID: 9299614 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]